Biology of Blood and Marrow Transplantation
Volume 15, Issue 5 , Pages 580-588 , May 2009

What Is the Role for Donor Natural Killer Cells after Nonmyeloablative Conditioning?

  • Frédéric Baron

      Affiliations

    • Giga Research, University of Liège, Liège, Belgium
    • ,
  • Effie W. Petersdorf

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
    • University of Washington, Seattle, Washington
    • ,
  • Ted Gooley

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
    • University of Washington, Seattle, Washington
    • ,
  • Brenda M. Sandmaier

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
    • University of Washington, Seattle, Washington
    • ,
  • Mari Malkki

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
    • University of Washington, Seattle, Washington
    • ,
  • Thomas R. Chauncey

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
    • University of Washington, Seattle, Washington
    • Veterans Affairs Medical Center, Seattle, Washington
    • ,
  • David G. Maloney

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
    • University of Washington, Seattle, Washington
    • ,
  • Rainer Storb

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
    • University of Washington, Seattle, Washington
    • Corresponding Author InformationCorrespondence and reprint requests: Rainer Storb, MD, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, D1-100, PO Box 19024, Seattle, WA 98109-1024.

Received 19 November 2008 ,Accepted 26 January 2009.

  • Image Result

    Probability of relapse in patients with all ligands for donor NK cell KIRs compared with those lacking 1 or more such ligands.

    Probability of relapse in patients with all ligands for donor NK cell KIRs compared with those lacking 1 or more such ligands.

 F.B. and E.W.P. contributed equally to this work.

 Financial disclosure: See Acknowledgments on page 587.

PII: S1083-8791(09)00063-9

doi: 10.1016/j.bbmt.2009.01.018

Biology of Blood and Marrow Transplantation
Volume 15, Issue 5 , Pages 580-588 , May 2009

Article Tools

* Image Usage & Resolution